ANI Pharmaceuticals traded at $31.15 this Tuesday July 5th, decreasing $0.39 or 1.22 percent since the previous trading session. Looking back, over the last four weeks, ANI Pharmaceuticals lost 8.54 percent. Over the last 12 months, its price fell by 7.32 percent. Looking ahead, we forecast ANI Pharmaceuticals to be priced at 30.68 by the end of this quarter and at 28.25 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
31.15
Daily Change
-1.22%
Yearly
-7.32%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 151.85 -1.95 -1.27% 31.21%
Aurora Cannabis Inc 1.71 0.02 1.18% -83.49%
Aerie Pharmaceuticals 8.58 0.22 2.63% -44.61%
ANI Pharmaceuticals 31.15 -0.39 -1.22% -7.32%
Depomed 3.20 0.05 1.57% 107.09%
Emergent BioSolutions 32.25 0.42 1.32% -47.71%
Endo International 0.59 0.02 4.33% -86.51%
Knight Therapeutics Inc 5.28 -0.12 -2.22% 0.57%
Hikma Pharmaceutical 1,632.00 -22.00 -1.33% -36.18%
Heron Therapeutics 2.80 0.08 2.94% -80.58%
Lannett 0.57 0.01 0.89% -87.63%
Eli Lilly 321.13 -3.58 -1.10% 36.41%
Nektar Therapeutics 3.73 -0.03 -0.67% -78.23%
Novartis 83.56 -0.80 -0.95% -8.76%
Omeros 4.16 -0.48 -10.34% -72.25%
Perrigo 40.03 -0.99 -2.41% -14.65%
Sun Pharmaceuticals 835.75 6.35 0.77% 24.14%
Teva Pharmaceutical Industries Ltd 2,746.00 0 0% -13.97%
Teva Pharmaceutical Industries 7.72 -0.18 -2.22% -19.72%
Canopy Growth Corp 3.49 -0.14 -3.86% -87.76%

Indexes Price Day Year
USND 11091 -36.38 -0.33% -24.36%
US2000 1707 -21.04 -1.22% -24.96%

ANI Pharmaceuticals
ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company. The Company is focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. The Company focuses on areas, including controlled substances, oncology products (anti-cancer), hormones and steroids, and complex formulations. Its products include Aminocaproic Acid Tablets USP, ApexiCon E (diflorasone diacetate cream USP (emollient)), Arimidex (anastrozole) tablets, Atacand HCT (candesartan cilexetil - hydrochlorothiazide) Tablets, Atacand (candesartan cilexetil) Tablets, Bexarotene Capsules, Bicalutamide Tablets USP, and more. Its branded products include Cortenema, Cortrophin gel, Cortrophin-Zinc, Inderal LA, Inderal XL, InnoPran XL, Lithobid, Reglan, and Vancocin. It operates across three pharmaceutical manufacturing facilities, of which two are located in Baudette, Minnesota and one is located in Oakville, Ontario.